GlaxoSmithKline planning Ebola vaccine: Altenpohl

Bloomberg

Email Print

RELATED NEWS

 
Donna Altenpohl, vice president of public policy at GlaxoSmithKline Plc, talks about the outlook for an Ebola Vaccine. She speaks with Scarlet Fu and Tom Keene on Bloomberg Television's "Surveillance." Bart Chilton, a senior policy adviser at DLA Piper LLP, also speaks.
 

More Health News